Amoxapine
From Wikipedia, the free encyclopedia
Amoxapine
|
|
Systematic (IUPAC) name | |
? | |
Identifiers | |
CAS number | 14028-44-5 |
ATC code | N06AA17 |
PubChem | 2170 |
DrugBank | APRD00142 |
Chemical data | |
Formula | C17H16ClN3O |
Mol. weight | 313.781 |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | Hepatic (cytochrome P450 system) |
Half life | 8-10 hours (30 hours for major metabolites) |
Excretion | Renal |
Therapeutic considerations | |
Pregnancy cat. |
C(US) |
Legal status |
℞-only(US) |
Routes | Oral |
Amoxapine (brand-names Asendin®, Asendis®, Defanyl®, Demolox®, Moxadil®) is a tetracyclic antidepressant of the dibenzoxazepine class. It is used in the treatment of depression, panic disorders and bipolar disorder.
Amoxapine is a strong reuptake inhibitor of norepinephrine and weak reuptake inhibitor of serotonin. One of its major metabolites, 7-hydroxyamoxapine, has a dopamine receptor blocking effect.
[edit] References
- Mosby Year-Book, Inc. (1995). Physician's GenRx: The Complete Drug Reference (5th Ed.). Riverside, CT: Denniston Publishing Co.
- Palfai, T. & Jankiewicz, H. (1997). Drugs and Human Behavior (2nd Ed.). Madison, WI: Brown & Benchmark.
- Hedges, D. & Burchfield, C. (2006). Mind, Brain, and Drug: An Introduction to Psychopharmacology. Boston, MA: Pearson.